[go: up one dir, main page]

AU4090093A - Medicine containing benzoic acid derivative and novel benzoic acid derivative - Google Patents

Medicine containing benzoic acid derivative and novel benzoic acid derivative

Info

Publication number
AU4090093A
AU4090093A AU40900/93A AU4090093A AU4090093A AU 4090093 A AU4090093 A AU 4090093A AU 40900/93 A AU40900/93 A AU 40900/93A AU 4090093 A AU4090093 A AU 4090093A AU 4090093 A AU4090093 A AU 4090093A
Authority
AU
Australia
Prior art keywords
benzoic acid
acid derivative
medicine containing
novel
containing benzoic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40900/93A
Inventor
Hiromu Hara
Susumu Igarashi
Masahiko Isaka
Takenori Kimura
Hiroshi Koutoku
Toshiyasu Mase
Hitoshi Nagaoka
Ryo Naito
Kenichi Tomioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP16414492A external-priority patent/JPH05331104A/en
Priority claimed from JP16842492A external-priority patent/JPH05331059A/en
Priority claimed from JP35594892A external-priority patent/JPH06183961A/en
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of AU4090093A publication Critical patent/AU4090093A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/90—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to a carbon atom of a six-membered aromatic ring, e.g. amino-diphenylethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/33—Polycyclic acids
    • C07C63/331—Polycyclic acids with all carboxyl groups bound to non-condensed rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU40900/93A 1992-05-29 1993-05-27 Medicine containing benzoic acid derivative and novel benzoic acid derivative Abandoned AU4090093A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP4-164144 1992-05-29
JP16414492A JPH05331104A (en) 1992-05-29 1992-05-29 New benzoic acid derivative or its salt
JP4-168424 1992-06-02
JP16842492A JPH05331059A (en) 1992-06-02 1992-06-02 Testosterone 5alpha-reductase inhibitor
JP4-355948 1992-12-18
JP35594892A JPH06183961A (en) 1992-12-18 1992-12-18 Medicine comprising benzoic acid derivative and new benzoic acid derivative

Publications (1)

Publication Number Publication Date
AU4090093A true AU4090093A (en) 1993-12-30

Family

ID=27322278

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40900/93A Abandoned AU4090093A (en) 1992-05-29 1993-05-27 Medicine containing benzoic acid derivative and novel benzoic acid derivative

Country Status (2)

Country Link
AU (1) AU4090093A (en)
WO (1) WO1993024442A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
FR2737721B1 (en) 1995-08-08 1997-09-05 Roussel Uclaf NOVEL BIPHENYL COMPOUNDS, THEIR PREPARATION METHOD AND INTERMEDIATES THEREOF, THEIR USE AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB9523946D0 (en) * 1995-11-23 1996-01-24 Bayer Ag Leukotriene antagonistic benzoic acid derivatives
US6017958A (en) * 1996-06-04 2000-01-25 Octamer, Inc. Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
US5736576A (en) * 1996-06-04 1998-04-07 Octamer, Inc. Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity
WO1998042328A1 (en) * 1997-03-26 1998-10-01 Biosource Technologies, Inc. Di-aryl ethers and their derivatives as anti-cancer agents
US6506798B1 (en) 1997-07-01 2003-01-14 Warner-Lambert Company 4-Arylamino, 4-aryloxy, and 4-arylthio diarylamines and derivatives thereof as selective MEK inhibitors
US6291442B1 (en) 1998-02-03 2001-09-18 The General Hospital Corporation Pharmacological modulators of voltage-gated potassium ion channels
AU1624801A (en) 1999-11-19 2001-05-30 Corvas International, Inc. Plasminogen activator inhibitor antagonists related applications
US6638977B1 (en) 1999-11-19 2003-10-28 Corvas International, Inc. Plasminogen activator inhibitor antagonists
US7001905B2 (en) 2000-03-15 2006-02-21 Warner-Lambert Company Substituted diarylamines as MEK inhibitors
EP1467968A1 (en) 2002-01-23 2004-10-20 Warner-Lambert Company LLC N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
DOP2003000556A (en) 2002-01-23 2003-10-31 Warner Lambert Co ESTERES HYDROXAMATE ACID N- (4-PHENYL-REPLACED) -ANTRANILICO.
US7012100B1 (en) 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
CA2511178A1 (en) 2002-12-20 2004-07-15 Migenix Corp. Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto
US7355049B2 (en) 2003-06-24 2008-04-08 Hoffmann-La Roche Inc. Biaryloxymethylarenecarboxylic acids as glycogen synthase activator
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
US7524870B2 (en) * 2004-12-03 2009-04-28 Hoffmann-La Roche Inc. Biaryloxymethylarenecarboxylic acids as glycogen synthase activators
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
MX2010002772A (en) 2007-09-21 2010-03-31 Array Biopharma Inc Pyridin-2 -yl-amino-i, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus.
GB0725214D0 (en) * 2007-12-24 2008-02-06 Karobio Ab Pharmaceutical compounds
AU2017232391C1 (en) * 2016-03-17 2022-12-22 Xeniopro GmbH Enhancers of notch signaling and their use in the treatment of cancers and malignancies medicable by upregulation of notch
WO2018154118A2 (en) * 2017-02-24 2018-08-30 Reinmueller Viktoria Novel aromatic compounds
EP3585485A2 (en) * 2017-02-24 2020-01-01 Xeniopro GmbH Aromatic compounds which enhance notch signaling, for use in therapy
IL315313A (en) * 2018-08-24 2024-10-01 Xeniopro GmbH Aromatic molecules for use in the treatment of pathological conditions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692828A (en) * 1970-05-01 1972-09-19 Gulf Research Development Co Process for preparing phenyl sulfone carboxylic acids
US3886162A (en) * 1972-07-19 1975-05-27 Syntex Inc Acridone carboxylic acids and derivatives
US3965146A (en) * 1973-06-04 1976-06-22 Raychem Corporation Biphenylyloxy benzoic acid and esters thereof
GB1543965A (en) * 1977-04-05 1979-04-11 Ici Ltd Substituted phenoxybenzoic acids and their esters and salts and herbicidal compositions containing them
DE3500972A1 (en) * 1985-01-14 1986-07-17 Henkel Kgaa SEBOSUPPRESSIVE COSMETIC AGENTS, CONTAINING ALKOXY OR ALKYLBENZYLOXY BENZOESAEUREN OR THEIR SALTS
JPH0730007B2 (en) * 1985-07-23 1995-04-05 旭硝子株式会社 Difluorocyano compound and liquid crystal composition containing the same
JPS6399036A (en) * 1986-10-15 1988-04-30 Asahi Chem Ind Co Ltd Production of aromatic hydroxycarboxylic acid
EP0291245B1 (en) * 1987-05-11 1992-07-22 Ono Pharmaceutical Co., Ltd. Benzoylaminophenoxybutanoic acid derivatives
DE3851262T2 (en) * 1987-06-04 1995-02-02 Ono Pharmaceutical Co Benzoylaminophenoxybutyric acid derivatives.
JP2684197B2 (en) * 1988-10-18 1997-12-03 セイミケミカル株式会社 Halogenocyanobenzene derivative compound and liquid crystal composition containing the same
DE3903989A1 (en) * 1989-02-10 1990-09-20 Basf Ag DIPHENYLHETEROALKYL DERIVATIVES, THEIR PREPARATION, AND MEDICAMENTS AND COSMETICS THEREOF

Also Published As

Publication number Publication date
WO1993024442A1 (en) 1993-12-09

Similar Documents

Publication Publication Date Title
AU4090093A (en) Medicine containing benzoic acid derivative and novel benzoic acid derivative
AU1388388A (en) Benzoic acid derivatives and use thereof
HU9303282D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
AU3105493A (en) Quinolone- and naphthyridone-carboxylic acid derivatives
AU4893993A (en) Carboxylic acid derivatives
NZ250762A (en) Five-membered-heterocyclic carboxylic acid derivatives and pharmaceutical compositions
AU7545894A (en) Carbamate derivative and medicine containing the same
AU3373293A (en) Anthraquinone compounds and pharmaceutical compositions containing them
AU1803092A (en) 7-azaisoindolinyl-quinolone- and-naphthyridonecarboxylic acid derivatives
AU5230693A (en) Carboxylic acid derivatives
HU9303283D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
AU1739192A (en) 7-isoindolinyl-quinolone- and -naphthyridonecarboxylic acid derivatives
AU5100393A (en) Diindolo compounds and pharmaceutical compositions containing them
AU3108293A (en) Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives
AU2602592A (en) Cyclic-substituted imidazolyl-propenoic acid derivatives
AU5067193A (en) Pyranoquinolines and their use as pharmaceuticals
AU5195693A (en) Substituted benzoic acids
AU3160893A (en) Novel bisphosphonic acid derivatives and their use
AU1282395A (en) Novel benzamide derivative and medicinal composition containing the same
AU2602392A (en) Imidazolyl-propenoic acid derivatives
AU2979892A (en) Thiazolyl-substituted quinolylmethoxphenylacetic acid derivatives
AU7001796A (en) Benzoic acid compounds and medicinal use thereof
AU5773794A (en) 4-amino-3-hydroxycarboxylic acid and their use as anitvirals
IL108920A0 (en) Acyloxyhexanoic acid derivatives and pharmaceutical compositions containing them
AU6944696A (en) Novel phenylacetic acid derivatives and medicinal composition containing the same